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ABSTRACT
The anti-infl ammatory and redox protective effects of the citronellal (CT) were evaluated using in vivo and in vitro tests. Intraperitoneal 
(i.p.) administration of CT (50, 100, and 200 mg/kg) inhibited (p < 0.05) the carrageenan-induced leukocyte migration to the peritoneal 
cavity. Additionally, the carrageenan- and arachidonic acid-induced rat hind paw edema was signifi cantly inhibited (p < 0.05) by i.p. 
administration of 100 and 200 mg/kg of the compound. When the redox activity was evaluated, CT (200 mg/kg) signifi cantly reduced 
hepatic lipoperoxidation (p < 0.001), as well as oxidation of plasmatic (p < 0.05) and hepatic (p < 0.01) proteins. The results of the present 
study support the hypothesis that CT possesses anti-infl ammatory and redox protective activities. It is suggested that its effects are 
associated with the inhibition of the enzymes in the arachidonic acid pathway, which prevent cell migration by inhibiting leukotriene 
production, edema formation and the increase of reactive oxygen species in tissues. Therefore, CT is of potential benefi t to manage 
infl ammatory disorders and correlated damages caused by oxidant agents.
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1. INTRODUCTION
Many plant-derived substances are attractive sources for 
developing new analgesic and anti-inflammatory agents. 
Among these natural products, monoterpenes are the primary 
components of plant essential oils and the effects of many 
medicinal herbs have been attributed to them (Gherlardini et 
al., 2001; De Sousa et al., 2006; De Sousa et al., 2007; Guimarães 
et al., 2010).
Citronellal (CT) is a monoterpene predominantly formed 
by the secondary metabolism of plants. It is typically isolated 
as a non-racemic mixture of its R and S enantiomers by steam 
distillation or solvent extraction from the oils of Corymbia 
citriodora Hill and Johnson (former Eucalyptus citriodora Hook) 
Cymbopogon nardus and C. winterianus (Lenardão et al., 2007). 
Preliminary behavioral screening realized with the essential 
oil of the C. winterianus, rich in CT, demonstrated its Central 
Nervous System (CNS) depressant and anticonvulsant 
activities (Quintans-Júnior et al., 2008). Additionally, Menezes 
et al. (2010) showed the hypotensive and vasorelaxant effects 
induced by C. winterianus essential oil in rats. Recently, CT 
showed CNS depressant and antinociceptive activities on 
unspecifi c and specifi c tests (Melo et al., 2010; Quintans-Júnior 
et al., 2010). However, little is known about the role of CT in 
infl ammatory and oxidative processes.
The purpose of the present study was to evaluate the anti-
infl ammatory and redox effects of CT using in vivo and in vitro 
tests.
2. MATERIALS AND METHODS
2.1. Drugs
Polyoxyethylene-sorbitan monolated (Tween 80), carrageenan, 
arachidonic acid, indomethacin and nordihydroguaiaretic 
acid were purchased from Sigma-Aldrich (USA), while 
dexamethasone was obtained from Cristália (Brazil). A 
racemic mixture of citronellal (CT) R and S enantiomers 
[(RS)-(±)-Citronellal] with 98% purity (Fig. 1) was purchased 
from Dierberger (Brazil).  Agents were administrated 
intraperitoneally (i.p.) at a dose of 0.1 mL/10 g (mice) and 0.1 
mL/100g (rats). For the redox experiments, all reagents were 
purchased from Sigma-Aldrich (USA). INSERT FIGURE 1
2.2. Animals
Male Swiss mice (30-35 g) and male Wistar rats (160-190 g), 
2-3 months of age, were used throughout this study. Animals 
were randomly housed in suitable cages at 25 ± 2 ºC on a 12 
h light/dark cycle (lights on 06:00-18:00 h) with free access 
to food (Purina®) and water, and were used in groups of 10 
animals each. All experiments were carried out between 09:00 
am and 16:00 pm in a quiet room. Experimental protocols 
and procedures were approved by the Animal Care and Use 
Committee at the Federal University of Sergipe (CEPA/UFS # 
12/08).
* Corresponding author: Lucindo J. Quintans-Júnior. Departamento de Fisiologia, Universidade Federal de Sergipe-UFS, Av. Marechal Rondom, s/n, São Cristóvão, Sergipe, Brazil. Tel.: 
+55-79-21056645; fax: +55-79-3212-6640. E-mail: lucindo_jr@yahoo.com.br; lucindo@pq.cnpq.br
Received: March 28, 2011. In revised form: July 15, 2011. Accepted: July 26, 2011.
Biol Res 44: 363-368, 2011
QUINTANS ET AL. Biol Res 44, 2011, 363-368364
2.3. Leukocyte migration to the peritoneal cavity
Leukocyte migration was induced by injection of carrageenan 
( 500 μg/cavity, i.p., 500 μL) into the peritoneal cavity of mice 
1 h after administration of CT (50, 100 and 200 mg/kg, i.p.) 
or dexamethasone (DEXA, 2 mg/kg, s.c.) using the technique 
previously described by Bastos et al. (2007) with modifi cations. 
The animals were euthanized by cervical dislocation 4 h after 
carrageenan injection. Shortly after, phosphate buffered saline 
(PBS) containing EDTA (1 mM, i.p., 10 mL) was injected in the 
peritoneal cavity. Immediately, a brief massage was done for 
further fl uid collection, which was centrifuged (2000×g for 5 
min) at room temperature. The supernatant was disposed and 
PBS (1 mL) was added to the precipitate. An aliquot of the 
precipitate suspension (10 μL) was dissolved in Turk solution 
(200 μL) for counting of the total cells in a Neubauer chamber 
under optic microscopy. The results were expressed as the 
number of leukocytes/mL. The percentage of the leukocyte 
inhibition was calculated as (1 – T/C) x 100, where T represents 
leukocyte counts for the treated groups and C represents 
leukocyte counts for the control (vehicle).
2.4. Carrageenan- and arachidonic acid-induced hind paw edema in rats
Paw edema was induced by an intraplantar administration 
of 0.1% carrageenan in normal saline solution (Winter et al., 
1962) or 0.5% arachidonic acid in 0.2 M carbonate buffer, pH 
8.2 (DiMartino et al., 1987) into the right hind paw of rats at a 
volume of 0.05 or 0.1 mL, respectively. The edema volume was 
determined using a plethysmometer (Model LE 7500 Panlab, 
Barcelona, Spain) (Winter et al., 1962) prior to and 3 h after 
carrageenan injection or 1 h after arachidonic acid injection. 
CT (50, 100 and 200 mg/kg, i.p.), control group (vehicle, 1 drop 
of Tween 80 0.2% in distilled water, the solvent for CT), and 
indomethacin (INDO, 10 mg/kg, i.p.) or nordihydroguaiaretic 
acid (NDGA, 100 mg/kg, i.p.) as reference drugs, were 
administered 1 h before injection of the phlogistic agents.
2.5. Redox-protective activity
One hour after administration of CT (200 mg/kg, i.p.) or saline, 
rats were anesthetized with thiopental sodium (45 mg/kg, i.p.). 
Blood was collected by cardiac puncture using heparinized 
syringes and immediately centrifuged (800×g, 15 min) at room 
temperature in presence of 2.5 mM butylated hydroxitoluene 
(BHT). The supernatant was quickly collected and placed on 
ice for determination of thiobarbituric acid (TBA) reactive 
substances (TBARS) and residual carbonyl derivatives (RCD) 
using Lapena et al. (2001) and Resnick & Packer (1994) modifi ed 
methods, respectively. At the same time, liver of rats was 
removed, washed three times with 1.15% potassium chloride 
(KCl) solution, dried, weighed, homogenized in 1.15% KCl 
and centrifuged (3000×g for 10 min) at room temperature in 
presence of 2.5 mM BHT. The supernatant was quickly collected 
and placed on ice for posterior analysis of TBARs and RCD.
2.6. Determination of TBARs
Aliquots of blood or liver samples (500 μL) were added to 
a reaction mixture (1 mL) containing equal amounts of 15% 
trichloroacetic acid (TCA), 0.25 N HCl, 0.375% TBA, 2.5 mM 
BHT and 8.1% sodium dodecyl sulphate (SDS, 100 μL). The 
pH of the reaction mixture was adjusted to 0.9 with HCl and 
then it was heated at 95 °C for 30 min in an oven. BHT was 
used to prevent lipid peroxidation during heating. After 
cooling the mixture to room temperature and adding 4 mL 
of n-butanol, reaction mixtures were centrifuged (800×g 
for 15 min) at room temperature in presence of 2.5 mM 
BHT. The supernatant was collected and its absorbance was 
measured at 532 nm. The molar extinction coeffi cient used to 
quantify malondialdehyde was 1.54 x 10-5 M-1 cm-1. Results 
as equivalents of malondialdehyde (MDA) were expressed in 
nmol.mL-1 plasma or nmol.g-1 tissue.
2.7. Determination of RCD
Aliquots of blood or liver samples (200 μL) were mixed with 
dinitrophenylhydrazine (DNPH, 800 μL), incubated at ± 37 
ºC for one hour in the dark. Mixtures were stired every 15 
min during the incubation period. Then, 15% TCA (1000 μL) 
was added to samples, which were centrifugated (1000×g 
for 10 min) at room temperature in presence of 2.5 mM BHT. 
The supernatant was then discarded and 15% TCA (800 μL) 
was added again to the precipitate and the resulting mixture 
stired. After centrifugation (1000×g for 10 min), the precipitate 
was washed three times with ethanol/ethyl acetate (1:1, 
800 μL) to remove the free DNPH and lipid contaminants. 
The final precipitate was resuspended in 6 M guanidine 
(400 μL) and incubated at ± 37 °C for 10 min. The insoluble 
material was removed by additional centrifugation (1000×g 
for 5 min) at room temperature, while the supernatant was 
collected. The molar extinction coeffi cient used to quantify 
spectrophotometrically the absorbance of the supernatant at 
360 nm was 22,000 M-1 cm-1. Results were expressed in nmol.
mL-1 plasma or nmol.g-1 tissue.
2.8. Statistical analysis
The data obtained in the anti-inflammatory tests were 
evaluated by one-way analysis of variance (ANOVA) followed 
Figure 1. The enantiomers of citronellal (racemic mixture - R and S 
enantiomers)
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by Tukey’s test. The data from the redox test were evaluated by 
Student’s t test. Differences were considered to be statistically 
signifi cant when p < 0.05.
3. RESULTS
Carrageenan increased leukocyte migration to the peritoneal 
cavity in the experimental animals 4 h after stimulation, which 
was characterized by the increase in the leukocyte number in 
the fl uid collected from the cavity. It was signifi cantly (p < 0.01) 
inhibited in 92.2% when mice were previously treated with the 
control drug dexamethasone (2 mg/kg, s.c.), as can be seen 
in Fig. 2. When CT was administered to mice, its inhibitory 
effect on the migration of leukocytes was dose-dependent, 
with inhibitions of 14, 46.1 and 65.6% at 50, 100 and 200 mg/kg 
(i.p.), respectively. However, it prevented signifi cantly (p < 0.05 
and p < 0.01, respectively) the carrageenan-induced peritonitis 
only at 100 and 200 mg/kg (s.c.). INSERT FIGURE 2
To determine the possible anti-infl ammatory effects of CT, 
carrageenan- and arachidonic acid-induced hind paw edema 
models in rats were used. When carrageenan was used as 
inductor of edema (Fig 3A), CT did not exhibit any signifi cant 
(p > 0.05) anti-infl ammatory effect when administered at 50 
mg/kg (i.p.), although the edema volume in this concentration 
was reduced in 5.5% when compared to the control (vehicle). 
However, at the highest tested concentrations, 100 and 200 
mg/kg (i.p.), CT inhibited signifi cantly (p < 0.05) the increase 
in the edema volume in 18.5 and 22.3%, respectively. Control 
drug, INDO (10 mg/kg, i.p.), showed the highest inhibition of 
edema volume (31%). INSERT FIGURE 3
NDGA administration (10 mg/kg, i.p.) produced a 
signifi cant (p < 0.01) and marked inhibition (49.6%) of the paw 
edematous response induced by arachidonic acid injection, 
as can be seen in Fig. 3B. When the rats were treated with CT 
Figure 2. Effect of CT on leukocyte migration to the peritoneal 
cavity induced by carrageenan: Groups of rats were pre-treated 
with vehicle, dexamethasone (DEXA, 2 mg/kg, s.c.) and CT (50, 
100 and 200 mg/kg, i.p.) 1 h before carrageenan administration 
(500 µg/cavity, i.p., 500 µL) to induce peritonitis. Cell counting 
was performed 4 h after the injection of carrageenan. Each 
value represents the mean ± S.E.M. Asterisks denote statistical 
signifi cance when means were compared to the vehicle group, 
where *p < 0.05 or **p < 0.01 by ANOVA followed by Tukey’s test.
Figure 3. Effects of indomethacin (INDO, 10 mg/kg, i.p.), 
nordihydroguaiaretic acid (NDGA, 100 mg/kg, i.p.) and CT (50, 
100 and 200 mg/kg, i.p.) on 1% carrageenan- (A) and 0.5% 
arachidonic acid- (B) induced hind paw edema in rats. Each 
value represents the mean of edema volume ± S.E.M. Asterisks 
denote statistical signifi cance when means were compared to 
the respective vehicle groups, where *p < 0.05 and **p < 0.01 by 
ANOVA followed by Tukey’s test.
previously to the administration of the fatty acid, it exerted 
a signifi cantly (p < 0.05) higher inhibitory effect on edema 
formation related to the induction caused by carrageenan 
because volume edema was reduced in 31, 34.1 and 38.8% at 
50, 100 and 200 mg/kg, respectively. INSERT FIGURE 4
When the redox-protective activity of CT was investigated, 
i t  was demonstrated CT could not minimize blood 
lipoperoxidation deleterious effects caused by reactive oxygen 
species (ROS) since the levels of TBARS represented by 
malondialdehyde were not signifi cantly (p > 0.05) reduced 
when compared the control vehicle (Fig 4A). However, 
lipoperoxidation in the hepatic tissue of rats was effectively 
reduced in 75.8% when compared to vehicle, as is shown in 
Fig. 4B. On the other hand, the investigation of the protective 
effect of CT on protein oxidation by carbonylation, which is 
characterized by the levels of RCDs, showed this monoterpene 
can prevent structural modifi cations of proteins in plasma and 
liver. Fig 5A shows a signifi cant (p < 0.05) inhibition of protein 
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oxidation in 28.1% in plasmatic samples, while a reduction of 
34.5%, also signifi cant (p < 0.01), was observed for liver tissues. 
INSERT FIGURE 5
4. DISCUSSION
Many studies have shown monoterpenes have pharmacological 
activities such as antinociceptive, anti-inflammatory and 
antioxidant (Almeida et al., 2001; De Sousa et al., 2006; De 
Sousa et al., 2007; Quintans-Júnior et al., 2010). Therefore, the 
aim of this study was to evaluate the anti-infl ammatory and 
antioxidant effects of citronellal (CT) using in vivo and in vitro 
tests.
The infl ammation induced by carrageenan involves cell 
migration and plasma exudation mediated by the production 
of inflammatory mediators such as histamine, serotonin, 
bradykinin, nitric oxide, interleukin (IL)-1β and IL-6, tumor 
necrosis factor (TNF)-α, and prostaglandins, which were 
previously shown to recruit leukocytes, such as neutrophils, in 
several experimental models (Salvemini et al., 1996; Loram et al., 
2007). In addition, it is known the production of prostaglandin 
E2, which is involved in cell migration and development of paw 
edema, increases 3 h after carrageenan administration through 
cyclooxygenase-2 (COX-2) activation (Ribeiro et al., 2010). 
Therefore, the compound is extensively used in studies assessing 
the anti-infl ammatory effect of steroidal and non-steroidal drugs 
(Vinegar et al., 1987). In the peritonitis model, CT acted similarly 
to DEXA, an immunosuppressant drug, by inhibiting leukocyte 
migration induced by i.p. injection of carrageenan in a dose-
dependent manner. CT also reduced the paw edema volume at 
100 and 200 mg/kg similarly to INDO, an infl ammatory drug 
well-known for affecting cyclooxygenase (COX) 1 and 2, the 
enzymes participating in the prostaglandin biosynthesis from 
arachidonic acid (DiMartino et al., 1987). Although a mechanism 
for this inhibition was not an aim in the present study, it can 
be suggested CT action on reducing cell migration and paw 
edema is associated with the inhibition of the biosynthesis of the 
infl ammatory mediators previously mentioned.
Arachidonic acid-induced paw edema in rat is also a 
widely used method for evaluating the anti-inflammatory 
activity of lipoxygenase inhibitors and other agents with 
a mechanism of action different from cyclooxygenase 
inhibitors. The lipoxygenase pathway uses arachidonic 
acid and 5-lipoxygenase to produce leukotrienes (LTs) such 
as LTC4 and LTD4, which are involved in inflammatory 
reactions as proinflammatory mediators and cause edema 
with increased microvascular permeability. Thus, owing to 
Figure 4. Redox-protective effect of CT (200 mg/kg, ip.) on MDA 
levels in plasma (A) and liver (B) of rats. Each value represents 
the mean ± S.E.M. Asterisks denote statistical signifi cance when 
means were compared to the respective vehicle groups, where 
***p < 0.001 by upaired Student’s t test (n = 8).
Figure 5. Redox-protective effect of CT (200 mg / kg, ip.) on RCD 
levels in plasma (A) and liver (B) of rats. Each value represents 
the mean ± S.E.M. Asterisks denote statistical signifi cance when 
means were compared to the respective vehicle groups, where *p 
< 0.05 and **p < 0.01 by unpaired Student’s t test.
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the contribution of leukotrienes to the pathogenesis of many 
inflammatory processes, they also represent an important 
target for therapeutic regulation. The paw edema induced 
by arachidonic acid is perceptibly reduced by lipoxygenase 
inhibitors and dual inhibitors of arachidonic acid metabolism 
such as phenidone and corticosteroids (DiMartino et al., 
1987). In the present study, CT inhibited the formation of 
edema by reducing its final volume in 30-40% similarly 
to NDGA. Contrary to INDO, which does not act on the 
lipooxygenase pathway of the arachidonic acid, NDGA is able 
to inhibit this enzyme and was used in the present study as 
the control drug (DiMartino et al., 1987; Trang et al., 2004). 
Thus, although lipoxygenase by-products were not measured, 
this fi nding suggests CT may be acting as an inhibitor of the 
enzyme lipoxygenase in the arachidonic acid metabolism. 
Further studies can establish if CT acts as a lipoxygenase only 
inhibitor or if it has a dual inhibitor role, inhibiting also the 
cyclooxygenases.
There is a consensus that during the inflammatory 
process, leukocytes cells such as eosinophils, basophils, 
neutrophils and monocytes are activated and interact with 
resident cells stimulating inflammatory and immunological 
mediators, whose metabolism can lead to the production 
of reactive oxygen species (ROS) (Barnes, 2008). ROS can 
activate nuclear factors of transcription and activator 
protein-1 (AP-1) and amplify the inflammatory response 
(Sugiura and Ichinose, 2008). Thus, CT effect on ROS 
production was investigated in a group of untreated rats 
by measuring the thiobarbituric acid-reactive substances 
(TBARS) such as malondialdehyde, a by-product of lipid 
peroxidation, and protein carbonyl group oxidation (Resnick 
& Packer, 1994; Lapenna et al., 2001). Although the study was 
performed in basal conditions, this primary investigation 
showed CT can reduce oxidation of lipids in liver and 
protein oxidation in liver and plasma of rats, which is an 
indicative of its potential as an anti-ROS agent. Further 
studies on the mechanisms by which CT is exerting its anti-
inflammatory activity can establish CT potential against 
ROS in inflammatory conditions. It is known that many 
antioxidants are first metabolized in the liver before their 
release in the blood stream (Vaziri et al., 2000). Therefore, 
this organ has a higher content of antioxidants, which will 
minimize ROS faster and in a more efficient way than in other 
organs. This may explain why lipids and proteins in liver 
were better protected in the present study.
According to Chiaradia et al. (2009), the evaluation of the 
chemical composition and in vitro antioxidant potential of 
the essential oil of citronella (C. winterianus) showed that CT 
is one of the major compounds (35.28%). Furthermore, the 
antioxidant potential of the oil is higher than observed for the 
essential oil of other vegetable species, which was believed 
to be directly proportional to the higher CT concentration. 
The mechanism whereby CT protects the cellular lipid and 
protein structures from oxidative action of ROS occurs 
through abstraction of one hydrogen atom or addiction of 
radical OH to the double carbon-carbon bond of CT (Harrison 
et al., 2007), thus preventing lipoperoxidation and protein 
oxidation (Lertsatitthanakorn et al., 2006). The results of the 
present study support the hypothesis that CT possesses anti-
infl ammatory and redox protective activities. Therefore, CT 
is of potential benefi t to manage infl ammatory disorders and 
correlated damages caused by oxidant agents.
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